Detalles de la búsqueda
1.
Tumor Mutational Burden as a Predictive Biomarker for Response to Immune Checkpoint Inhibitors: A Review of Current Evidence.
Oncologist
; 25(1): e147-e159, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31578273
2.
Biomarkers in Breast Cancer: An Integrated Analysis of Comprehensive Genomic Profiling and PD-L1 Immunohistochemistry Biomarkers in 312 Patients with Breast Cancer.
Oncologist
; 25(11): 943-953, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32869930
3.
Landscape of Biomarkers in Non-small Cell Lung Cancer Using Comprehensive Genomic Profiling and PD-L1 Immunohistochemistry.
Pathol Oncol Res
; 27: 592997, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34257540
4.
Budget impact analysis of comprehensive genomic profiling in patients with advanced non-small cell lung cancer.
J Med Econ
; 22(2): 140-150, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30430885
5.
Effect of a Collaboration Between a Health Plan, Oncology Practice, and Comprehensive Genomic Profiling Company from the Payer Perspective.
J Manag Care Spec Pharm
; 25(5): 601-611, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30632889
6.
Real-world utilization of molecular diagnostic testing and matched drug therapies in the treatment of metastatic cancers.
J Med Econ
; 21(6): 543-552, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29295635
7.
Estimated Cost of Anticancer Therapy Directed by Comprehensive Genomic Profiling in a Single-Center Study.
JCO Precis Oncol
; 22018.
Artículo
en Inglés
| MEDLINE | ID: mdl-32913996
8.
Delivering Precision Oncology in a Community Cancer Program: Results From a Prospective Observational Study.
JCO Precis Oncol
; 2: 1-12, 2018 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-35135120
Resultados
1 -
8
de 8
1
Próxima >
>>